Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

Clinical trial NCT00305487 · COMPLETED

Trial details

NCT number: NCT00305487
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hay Fever Seasonal Allergic Rhinitis

Start date: 2006-03-01
Primary completion: 2006-10-01
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.